Modulation of Glutamate and Aspartate Release from Slices of Hippocampal Area CA1 by Inhibitors of Arachidonic Acid Metabolism

Cathleen L Peterson-Layne, Michael A. Thompson, David Martin, J. Victor Nadler

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Abstract: Slices of hippocampal area CA1 were used to test inhibitors of arachidonic acid metabolism for their effects on glutamate/aspartate release from the CA3‐derived Schaffer collateral, commissural, and ipsilateral associational terminals. Test compounds [3 µM nordihydroguaiaretic acid (NDGA) and 1 µM 3‐[3‐(4‐chlorobenzyl)‐3‐tert‐butylthio‐5‐isopropylindol‐2‐yl]‐2,2‐dimethyl‐propanoic acid (MK‐886)] that reduced the production and release of 5‐lipoxygenase metabolites also selectively reduced the K + ‐evoked release of aspartate. In contrast, the cyclooxygenase inhibitor indomethacin (100 µM) selectively enhanced the release of glutamate. At a concentration (100 µM) that nonselectively depressed the release of arachidonic acid and its metabolites, NDGA markedly depressed the release of aspartate, glutamate, and GABA. An inhibitor of the 12‐lipoxygenase and an inhibitor of nitric oxide synthase did not affect the K + ‐evoked release of any transmitter amino acid. These results suggest that a 5‐lipoxygenase product selectively enhances aspartate release and a cyclooxygenase product selectively depresses glutamate release. They are also consistent with previous evidence that arachidonic acid and/or platelet‐activating factor enhances the release and depresses the uptake of glutamate and aspartate. The K + ‐evoked release of excitatory amino acids is much more sensitive to modulation by lipid mediators than is GABA release. Activation of NMDA receptors may enhance the K + ‐evoked release of glutamate and aspartate from CA1 slices by stimulating the production and release of lipid modulators.

Original languageEnglish (US)
Pages (from-to)1152-1160
Number of pages9
JournalJournal of Neurochemistry
Volume64
Issue number3
DOIs
StatePublished - Jan 1 1995

Fingerprint

Arachidonic Acid
Metabolism
Aspartic Acid
Glutamic Acid
Modulation
Masoprocol
Metabolites
gamma-Aminobutyric Acid
Lipids
Excitatory Amino Acids
Cyclooxygenase Inhibitors
Prostaglandin-Endoperoxide Synthases
N-Methyl-D-Aspartate Receptors
Nitric Oxide Synthase
Indomethacin
Modulators
Transmitters
Hippocampus
Chemical activation
Amino Acids

Keywords

  • Arachidonic acid
  • Aspartate
  • Glutamate
  • Hippocampus
  • Lipid mediators
  • Transmitter release

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Modulation of Glutamate and Aspartate Release from Slices of Hippocampal Area CA1 by Inhibitors of Arachidonic Acid Metabolism. / Peterson-Layne, Cathleen L; Thompson, Michael A.; Martin, David; Nadler, J. Victor.

In: Journal of Neurochemistry, Vol. 64, No. 3, 01.01.1995, p. 1152-1160.

Research output: Contribution to journalArticle

Peterson-Layne, Cathleen L ; Thompson, Michael A. ; Martin, David ; Nadler, J. Victor. / Modulation of Glutamate and Aspartate Release from Slices of Hippocampal Area CA1 by Inhibitors of Arachidonic Acid Metabolism. In: Journal of Neurochemistry. 1995 ; Vol. 64, No. 3. pp. 1152-1160.
@article{d5d4e46d9135468f8ac9a18e337d6f1d,
title = "Modulation of Glutamate and Aspartate Release from Slices of Hippocampal Area CA1 by Inhibitors of Arachidonic Acid Metabolism",
abstract = "Abstract: Slices of hippocampal area CA1 were used to test inhibitors of arachidonic acid metabolism for their effects on glutamate/aspartate release from the CA3‐derived Schaffer collateral, commissural, and ipsilateral associational terminals. Test compounds [3 µM nordihydroguaiaretic acid (NDGA) and 1 µM 3‐[3‐(4‐chlorobenzyl)‐3‐tert‐butylthio‐5‐isopropylindol‐2‐yl]‐2,2‐dimethyl‐propanoic acid (MK‐886)] that reduced the production and release of 5‐lipoxygenase metabolites also selectively reduced the K + ‐evoked release of aspartate. In contrast, the cyclooxygenase inhibitor indomethacin (100 µM) selectively enhanced the release of glutamate. At a concentration (100 µM) that nonselectively depressed the release of arachidonic acid and its metabolites, NDGA markedly depressed the release of aspartate, glutamate, and GABA. An inhibitor of the 12‐lipoxygenase and an inhibitor of nitric oxide synthase did not affect the K + ‐evoked release of any transmitter amino acid. These results suggest that a 5‐lipoxygenase product selectively enhances aspartate release and a cyclooxygenase product selectively depresses glutamate release. They are also consistent with previous evidence that arachidonic acid and/or platelet‐activating factor enhances the release and depresses the uptake of glutamate and aspartate. The K + ‐evoked release of excitatory amino acids is much more sensitive to modulation by lipid mediators than is GABA release. Activation of NMDA receptors may enhance the K + ‐evoked release of glutamate and aspartate from CA1 slices by stimulating the production and release of lipid modulators.",
keywords = "Arachidonic acid, Aspartate, Glutamate, Hippocampus, Lipid mediators, Transmitter release",
author = "Peterson-Layne, {Cathleen L} and Thompson, {Michael A.} and David Martin and Nadler, {J. Victor}",
year = "1995",
month = "1",
day = "1",
doi = "10.1046/j.1471-4159.1995.64031152.x",
language = "English (US)",
volume = "64",
pages = "1152--1160",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Modulation of Glutamate and Aspartate Release from Slices of Hippocampal Area CA1 by Inhibitors of Arachidonic Acid Metabolism

AU - Peterson-Layne, Cathleen L

AU - Thompson, Michael A.

AU - Martin, David

AU - Nadler, J. Victor

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Abstract: Slices of hippocampal area CA1 were used to test inhibitors of arachidonic acid metabolism for their effects on glutamate/aspartate release from the CA3‐derived Schaffer collateral, commissural, and ipsilateral associational terminals. Test compounds [3 µM nordihydroguaiaretic acid (NDGA) and 1 µM 3‐[3‐(4‐chlorobenzyl)‐3‐tert‐butylthio‐5‐isopropylindol‐2‐yl]‐2,2‐dimethyl‐propanoic acid (MK‐886)] that reduced the production and release of 5‐lipoxygenase metabolites also selectively reduced the K + ‐evoked release of aspartate. In contrast, the cyclooxygenase inhibitor indomethacin (100 µM) selectively enhanced the release of glutamate. At a concentration (100 µM) that nonselectively depressed the release of arachidonic acid and its metabolites, NDGA markedly depressed the release of aspartate, glutamate, and GABA. An inhibitor of the 12‐lipoxygenase and an inhibitor of nitric oxide synthase did not affect the K + ‐evoked release of any transmitter amino acid. These results suggest that a 5‐lipoxygenase product selectively enhances aspartate release and a cyclooxygenase product selectively depresses glutamate release. They are also consistent with previous evidence that arachidonic acid and/or platelet‐activating factor enhances the release and depresses the uptake of glutamate and aspartate. The K + ‐evoked release of excitatory amino acids is much more sensitive to modulation by lipid mediators than is GABA release. Activation of NMDA receptors may enhance the K + ‐evoked release of glutamate and aspartate from CA1 slices by stimulating the production and release of lipid modulators.

AB - Abstract: Slices of hippocampal area CA1 were used to test inhibitors of arachidonic acid metabolism for their effects on glutamate/aspartate release from the CA3‐derived Schaffer collateral, commissural, and ipsilateral associational terminals. Test compounds [3 µM nordihydroguaiaretic acid (NDGA) and 1 µM 3‐[3‐(4‐chlorobenzyl)‐3‐tert‐butylthio‐5‐isopropylindol‐2‐yl]‐2,2‐dimethyl‐propanoic acid (MK‐886)] that reduced the production and release of 5‐lipoxygenase metabolites also selectively reduced the K + ‐evoked release of aspartate. In contrast, the cyclooxygenase inhibitor indomethacin (100 µM) selectively enhanced the release of glutamate. At a concentration (100 µM) that nonselectively depressed the release of arachidonic acid and its metabolites, NDGA markedly depressed the release of aspartate, glutamate, and GABA. An inhibitor of the 12‐lipoxygenase and an inhibitor of nitric oxide synthase did not affect the K + ‐evoked release of any transmitter amino acid. These results suggest that a 5‐lipoxygenase product selectively enhances aspartate release and a cyclooxygenase product selectively depresses glutamate release. They are also consistent with previous evidence that arachidonic acid and/or platelet‐activating factor enhances the release and depresses the uptake of glutamate and aspartate. The K + ‐evoked release of excitatory amino acids is much more sensitive to modulation by lipid mediators than is GABA release. Activation of NMDA receptors may enhance the K + ‐evoked release of glutamate and aspartate from CA1 slices by stimulating the production and release of lipid modulators.

KW - Arachidonic acid

KW - Aspartate

KW - Glutamate

KW - Hippocampus

KW - Lipid mediators

KW - Transmitter release

UR - http://www.scopus.com/inward/record.url?scp=0028847907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028847907&partnerID=8YFLogxK

U2 - 10.1046/j.1471-4159.1995.64031152.x

DO - 10.1046/j.1471-4159.1995.64031152.x

M3 - Article

VL - 64

SP - 1152

EP - 1160

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 3

ER -